S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

NCT00003590 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

NETWORK

Sponsor class

Conditions

Adult Meningioma

Interventions

DRUG: hydroxyurea

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]